Literature DB >> 26027527

Regulators and industry tackle dose-finding issues.

Asher Mullard.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26027527     DOI： 10.1038/nrd4644

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

Review 1.  The future of drug development: advancing clinical trial design.

Authors:  John Orloff; Frank Douglas; Jose Pinheiro; Susan Levinson; Michael Branson; Pravin Chaturvedi; Ene Ette; Paul Gallo; Gigi Hirsch; Cyrus Mehta; Nitin Patel; Sameer Sabir; Stacy Springs; Donald Stanski; Matthias R Evers; Edd Fleming; Navjot Singh; Tony Tramontin; Howard Golub
Journal:  Nat Rev Drug Discov       Date:  2009-10-09       Impact factor: 84.694
  1 in total
  1 in total

1.  Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1.

Authors:  Ariel Lewis-Ballester; Shay Karkashon; Dipanwita Batabyal; Thomas L Poulos; Syun-Ru Yeh
Journal:  J Am Chem Soc       Date:  2018-06-27       Impact factor: 15.419
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.